← Back to news
S

Seeking Alpha: News

Corcept Therapeutics GAAP EPS of $0.20 misses by $0.07, revenue of $202.1M misses by $52.84M

S

Realty Income Q4 earnings, guidance fail to impress

S

SLR Investment posts mixed Q4 results, NII marginally below dividend level

S

SA analyst: Tariffs, the Middle East, Dollar decline set stage for sudden volatility across assets

S

Vir Biotechnology launches $200M public stock offering

S

Trump to call for new tax cuts in SOTU - reports

S

Trex Non-GAAP EPS of $0.04 beats by $0.05, revenue of $161M beats by $16.62M

S

BridgeBio Pharma GAAP EPS of -$1.00 misses by $0.33, revenue of $154.2M beats by $5.13M

S

Day One Biopharmaceuticals reports Q4 results

S

Axon Enterprise Non-GAAP EPS of $2.15 beats by $0.55, revenue of $796.72M beats by $41.43M

S

Tempus AI Non-GAAP EPS of -$0.04 beats by $0.01, revenue of $367.2M beats by $3.81M

S

Shoals targets $560M–$600M 2026 revenue amid record backlog and new product launches

B

Harmony Biosciences targets $1B–$1.04B WAKIX revenue in 2026 while expanding late-stage CNS pipeline

B

Boaz Weinstein sounds the alarm on private credit: 'the wheels are coming off'

B

Cheniere Energy cut at Morgan Stanley, turning cautious as global LNG market moves into oversupply

B

Tennant targets $250M AMR revenue by 2028 as ERP challenges reshape 2026 outlook

B

Primoris outlines $5.35–$5.55 EPS guidance for 2026 amid record $11.9B backlog and energy market growth

B

Henry Schein outlines 2026 EPS growth target of 5%–8% and strategic initiatives amid leadership transition

B

Diamondback signals Barnett ramp-up with 900 locations, targeting cost reductions and development acceleration

B

Boise Cascade outlines $45M–$55M Q1 EBITDA target for BMD amid leadership transition and continued margin focus

B

Accenture offers AI opportunity after selloff, UBS says

S

PPL raised at Barclays, set up for constructive Pennsylvania rate case

S

NexPoint Residential outlines 2026 core FFO guidance range of $2.42-$2.71 per share amid Sun Belt market inflection expectations

S

Payoneer applies for U.S. national bank charter

S

UFP Industries targets $100M Deckorators sales jump in 2026 as capacity expands, cost savings accelerate

S

Oncolytics Biotech gains as enrollments for GIT cancer trial conclude

S

Embraer unveils upgraded Praetor jets to tap strong business aviation demand

S

Westlake Chemical Partners signals distributable cash flow recovery in 2026 with no planned turnarounds

S

Rio Tinto downgraded at Barclays with 'headwinds incoming'

S

Number of banks in 'Problem Bank List' rises in Q4 2025 - FDIC

S

U.S. private school tuition nears $50K as costs climb, boarding programs face pressure

S

Ovintiv outlines return of 75% free cash flow to shareholders in 2026 as portfolio transformation completes

S

Repligen outlines $810M–$840M 2026 revenue target while expanding analytics and protein franchises

S

NRG targets 14% annual EPS growth through 2030 as LS Power integration outperforms

S

Hegseth gives Anthropic deadline to remove safeguards; threatens use of Defense Production Act: report

S

ACV Auctions falls to record low as profit outlook rattles Wall Street

S

Protara falls after mid-stage trial data for lead asset in bladder cancer

S

IBM's Anthropic-induced sell-off overlooks the fact it's disrupting itself: Jefferies

S

Seaport turns bullish on Fox as stock pullback post-earnings 'overdone'

S

Lineage Q4 2025 Earnings Preview

S

Immunocore Q4 2025 Earnings Preview

S

Hippo Holdings Q4 2025 Earnings Preview

S

Compania Cervecerias Unidas S.A. Q4 Earnings Preview

S

Grupo Aeroportuario Q4 2025 Earnings Preview

S

Fidelity National projects 30% revenue growth in 2026 as it doubles down on AI and banking innovation

S

Xometry outlines at least 21% revenue growth for 2026 with leadership transition and expanding enterprise adoption

S

Leonardo DRS targets 6%-8% organic revenue growth in 2026 while ramping investment in innovation and capacity

S

What’s next for Blue Owl after the private credit storm?

S

Kuwait seeking BlackRock, Brookfield for potential $7B oil pipeline deal - Reuters

S

Pfizer wins full FDA approval for Braftovi in colorectal cancer

B